Catalogue | NJF01030, NJF01060, NJF01125, NJF01250, NJF01500 (Corresponding concentrations respectively: 0.03EU/mL, 0.06EU/mL, 0.125EU/mL, 0.25EU/mL, 0.5EU/mL) |
Method | Gel Clot |
| Specification | 10 vials/kit |
| Sample | Sample solutions of pharmaceuticals, biological products, and medical devices for quality control purposes |
| Storage | 2-8℃ |
The sample solution is mixed with the reconstituted TAL reagent in a test tube.
Endotoxin (if present) activates Factor C, initiating a cascade that converts proclotting enzyme to clotting enzyme.
The clotting enzyme catalyzes the coagulation of a coagulogen protein in the lysate.
After incubation at 37°C for 60±2 minutes, the formation of a firm, non-flowing gel upon tube inversion indicates a positive result.